One of the characteristics of aggressive periodontitis (AgP) is familial aggregation.
| INTRODUC TI ON
One of the characteristics of aggressive periodontitis (AgP) is familial aggregation. 1 A number of studies have attempted to identify genetic risk factors for AgP. A single nucleotide polymorphism (SNP) in interleukin-1 (IL-1) was the first identified genetic risk factor for AgP. 2 However, subsequent studies with improved statistical power using samples from homogeneous populations did not validate associations between IL-1 variants and periodontitis. [3] [4] [5] [6] [7] [8] Subsequently,
several genes have been identified as genetic risk factors for AgP, but the full complement of associated genes has not been fully elucidated. Hypothesis for the selection of the candidate gene is entirely dependent on knowledge regarding the molecular biological mechanisms of the disease. Therefore, hundreds of genes, which may have an effect on the disease, were not selected, as their functions were unknown or they lie within pathways that were not shown to be implicated with the disease. Accordingly, identification of novel AgP risk factors using candidate-gene selection is potentially biased, and most associations observed in previous candidate-gene studies were not successfully replicated.
The era of genomewide association study (GWAS) has emerged since 2005 and has provided a comprehensive and hypothesis-free strategy to identify novel genetic risk factors for diseases. In dental research, this unbiased strategy had been anticipated to identify genetic risk factors for AgP. 9 However, it took a long time to obtain reasonable and reliable results due to the lack of samples of the rare disease, AgP. 10 Therefore, it is important to review the identification of novel genetic risk factors for AgP through GWAS.
Periodontitis is a complex oral disease characterized by chronic infection and inflammation of tooth-supporting tissues, including alveolar bone, periodontal ligament, and root cementum. 11 There are two major forms of periodontitis; chronic periodontitis (CP) and AgP. CP is the most common form of periodontal disease and the major cause of tooth loss among adults over 40 years old. Compared with CP, AgP is a severe form of periodontitis. CP is generally considered to be slowly progressing periodontal disease compared with
AgP. The progression of bone destruction in CP patients is less than that in AgP patients. 12 Nevertheless, a severe periodontal breakdown is rare in both younger AgP patients and older CP patients. 13 Therefore, while AgP and CP are defined as different forms of periodontitis, there are a number of similarities between them. 13 AgP is a rapid and severe progressing form of periodontitis. 3, 27 This review mainly summarizes the current knowledge regarding genetic risk factors for AgP that reach the threshold for genomewide significance. We also review suggestive associations of common variants with susceptibility to AgP through a case-control GWAS and replication study. We also summarize the shared genetic risk factors for coronary heart disease and AgP identified through a case-control GWAS and replication study.
| G LT6 D1
Intronic SNP rs1537415 in glycosyltransferase 6 domain containing 1 (GLT6D1) was the first genetic risk factor for AgP to be identified using GWAS. GWAS was performed in a Dutch-German localized 
| DEFA1AAND SIG LEC5
Defensins are a family of antimicrobial peptides produced mainly by Paneth cells and neutrophil granulocytes. Defensins are classified into three families; α-defensin, β-defensin, and θ-defensin. Human α-defensin is expressed in gingival crevicular fluid and has antibacterial and antifungal activities. 29 rs2738058 of defensin α1 and α3
(DEFA1A3) was identified as a genetic risk factor for IgA neuropathy using a case-control GWAS in a Chinese Han population with a Pvalue of 2.31 × 10
, an OR of 1.267 and a 95% CI of 1.214-1.323. 30 More recently, GWAS of German, Dutch, and Turkish AgP and CP samples was performed using case-control analysis in approximately 2050 cases and 8500 subjects. DEFA1A3 SNPs, rs2978951, and rs2738058 successfully showed genomewide significance with 
| PF4/PPB P/C XCL5 AND I L-10
To our knowledge, the above three genes are the known genetic risk factors for AgP that meet the genomewide significance threshold. We next describe suggestive genetic risk factors for AgP (Pvalue > 5 × 10 −8 ) through a case-control GWAS or replication study.
SNP rs1595009 in gene cluster PF4/PPBP/CXCL5 was identified as a genetic risk factor associated with AgP in a German population with a P-value of 1.3 × 10 −4 (OR of 1.32 and 95% CI of 1.15-1.52).
After a replication study with German CP cases, SNP rs1595009
was associated with German AgP and CP subjects with a P-value of 2.9 × 10 −5 (OR of 1.2 and 95% CI of 1.1-1.3). through a case-control replication study 32 ( Table 2 ). TA B L E 2 Suggestive genetic risk factors for AgP through a case-control GWAS and replication study rs2679895, associated with AgP with P-value of 1.6 × 10 −3 , OR of 1.27, and 95% CI of 1.09-1.47 through a case-control replication study. 35 
| SUG G E S TIVE A SSO CIATI ON OF COMMON VARIANTS

| S HARED G ENE TI C RIS K FAC TOR S FOR CORONARY HE ART D IS E A S E AND A g P
A series of studies of periodontal medicine suggests an association between periodontal disease and systemic diseases, including diabetes 36 and coronary heart disease. 37, 38 A meta-analysis of five cohort studies including 86 092 subjects revealed that individuals with periodontal disease had a higher risk of developing coronary heart disease compared with the individuals without periodontal disease with a P-value of <0.001, an OR of 1.14, and a 95% CI of 1.074-1.213. 37 Because of the strong association between coronary heart disease and periodontitis, several studies have attempted to identify the shared genetic risk factors for coronary heart disease and AgP. The results of four independent GWAS showed that the long non-coding RNA of CDKN2B-AS1, which is located at chromosome 9p21.3 in tumor suppressor genes such as CDKN2A and CDKN2B, is strongly associated with coronary heart disease. 
| IDENTIFI C ATI ON OF G ENE TI C RIS K FAC TOR S FOR A g P THROUG H IDENTIT Y-BY-DE SCENT MAPPING
More recently, nucleotide-binding oligomerization domain-containing protein 2 (NOD2) was identified as a genetic risk factor for AgP in a Japanese population using identity-by-descent analysis. In this study, whole-exome sequencing of two families of multiple patients was performed, including five AgP patients. After filtration using non-parametric identity-by-descent mapping and Sanger sequencing, a missense mutation in NOD2 was identified as a genetic risk factor among the AgP patients. NOD2 SNP rs571102620 was identified as a common genetic variant in the first family and SNP rs104895427 was identified as a common genetic variant in the second family. Target exon sequencing in NOD2 was then performed using 94 genetically unrelated Japanese AgP patients and NOD2
SNPs, rs199858111 and rs765857594, and p.Ala868Thr, were absent or very (MAF ≤0.001) in this Asian population. 54 However, this study only reported a heterozygous rare mutation, which was found in only two families with periodontitis. It is possible that this rare variant is genetically neutral. To confirm that missense mutations in NOD2 are genetic risk factors for AgP, further following studies such as demonstrating a heterozygous effect in a functional analysis and a putative effect relating to periodontitis are necessary.
| IDENTIFI C ATI ON OF G ENE TI C RIS K FAC TOR S FOR A g P THROUG H WHOLE-E XOME S EQUEN CING AND FUN C TIONAL ANALYS IS
Recently, our group identified two genetic risk factors for AgP,
G protein-coupled receptor 126 (GPR126) and Sphingomyelin
Phosphodiesterase 3 (SMPD3), in a Japanese population. We performed whole-exome sequencing of 44 unrelated AgP patients;
however, because the number of subjects was small, these genetic variants did not reach genomewide significance: A P-value of calcification-related genes, while GPR126 SNP rs536714306 had no effect on the expression of calcification-related genes.
Similarly, we analyzed the involvement of SMPD3 SNP rs145616324 in HPDL cytodifferentiation. An associated variant of SMPD3, which encodes neutral sphingomyelinase 2 (nSMase 2), is a key molecule for skeletal development as well as cytodifferentiation of odontoblasts and alveolar bone. We demonstrated that wild-type SMPD3 upregulated calcification-related genes, whereas its SNP rs145616324 did not. These results indicate that GPR126 rs536714306 and SMPD3 rs145616324 are genetic risk factors for AgP in a Japanese population and rs145616324 negatively regulates the cytodifferentiation of HPDL cells in vitro; therefore, we concluded that rs536714306 and rs145616324 associate with the pathogenesis and progression of Japanese AgP. 55, 56 However, these studies had many pitfalls. Because the missense mutation in GPR126 SNP rs536714306 was only heterozygous in AgP patients, it is possible that the observed association is not causative but neutral. Although most of the missense mutations in GPR126 SNP rs536714306 and SMPD3 SNP rs145616324 were heterozygous in AgP patients, we performed in vitro functional analysis with a hemizygous background.
| IDENTIFI C ATI ON OF CP G ENE TI C RIS K FAC TOR S US ING GWA S
One genetic risk factor, SNP rs149133391 in TSNAX-DISC1, has been identified to have genomewide significant association with CP through a Hispanic case-control GWAS (n = 10 935) with a P-value of 7.9 × 10 −9
. rs149133391 also showed association with African American CP subjects (n = 4314) with a P-value of 9.1 × 10 −3 through a replication study. 5 Since rare variants occur less frequently, association studies require larger sample sizes to achieve the necessary statistical power. In addition, if a GWAS study investigates common variants (which are <1000 000) as well as all rare variants, the number of independent tests increases, which requires the threshold indicating significance to be lowered. It is worth noting that distinguishing false positives from false negatives of rare variant associations is difficult in this study. 59 Thus, we cannot consider SNP rs149133391 in TSNAX-DISC1 as a definitive significant risk factor for CP.
There , OR = 1.41, and 95% CI = 1.24-1.60). 6 Six genes showed a suggestive association: four genes with severe CP [NIN (a P-value = 1.6 × 10 −7 ), ABHD12B (a P-value = 3.6 × 10 −7 ),
), and AP3B2 (a P-value = 2.2 × 10 and 95% CI of 1.92-4.27) 8 (Table 3) . Turkish subjects 3 and was a suggestive genetic risk factor for CP in German subjects. 4 SNP rs1047031 of DEFB1 was a suggestive genetic risk factor for AgP and CP in German and Dutch subjects. 61 Interestingly, several studies have demonstrated that several SNPs in the defensin family were genetic risk factors for periodontitis as assessed by Sanger sequencing. 62, 63 Defensin family proteins are known to be secreted by the immune system to maintain the balance between healthy and disease conditions 64 ; therefore, the defensin family might play an important role in the pathogenesis and progression of periodontitis. It is worth noting that while DEFA1A3 is associated with both AgP and CP, GLT6D1 is associated only with AgP. 27 In conclusion, three genes have so far been identified as genetic risk factors for AgP. While it is difficult to identify a genetic risk factor for AgP with significant genomewide association, GWAS could uncover new strategies to identify AgP genetic risk factors. TA B L E 3 Genetic risk factors for CP identified through case-control GWAS
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